Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
45
PCRX Quote, Financials, Valuation and Earnings
Last price:
$26.01
Seasonality move
:
13.08%
Day range:
$25.56 - $26.19
52-week range:
$18.17 - $27.64
Dividend yield:
0%
P/E ratio:
58.33x
P/S ratio:
1.68x
P/B ratio:
1.54x
Volume:
382.4K
Avg. volume:
801.1K
1-year change:
33.64%
Market cap:
$1.1B
Revenue:
$701M
EPS (TTM):
$0.45
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $429.6M | $541.5M | $666.8M | $675M | $701M | |
| Revenue Growth (YoY) | 2.05% | 26.04% | 23.14% | 1.22% | 3.85% | |
| Cost of Revenues | $125.2M | $153.8M | $256.6M | $242M | $227.7M | |
| Gross Profit | $304.5M | $387.7M | $410.2M | $433M | $473.3M | |
| Gross Profit Margin | 70.86% | 71.6% | 61.52% | 64.15% | 67.51% | |
| R&D Expenses | $59.4M | $55.5M | $84.8M | $76.3M | $81.6M | |
| Selling, General & Admin | $164.4M | $168.5M | $219M | $235.8M | $259.2M | |
| Other Inc / (Exp) | -$10.4M | -$45.6M | -$22.2M | -$16.8M | -$163.8M | |
| Operating Expenses | $252.9M | $254.9M | $339.3M | $345.7M | $375.7M | |
| Operating Income | $51.5M | $132.8M | $70.9M | $87.3M | $97.6M | |
| Net Interest Expenses | $25.7M | $31.8M | $40M | $20.3M | $16.6M | |
| EBT. Incl. Unusual Items | $20.1M | $56.4M | $13.3M | $61.7M | -$63.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$125.4M | $14.4M | -$2.6M | $19.7M | $36.5M | |
| Net Income to Company | $145.5M | $42M | $15.9M | $42M | -$99.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $145.5M | $42M | $15.9M | $42M | -$99.6M | |
| Basic EPS (Cont. Ops) | $3.41 | $0.95 | $0.35 | $0.91 | -$2.15 | |
| Diluted EPS (Cont. Ops) | $3.33 | $0.92 | $0.34 | $0.81 | -$2.15 | |
| Weighted Average Basic Share | $42.7M | $44.3M | $45.5M | $46.2M | $46.2M | |
| Weighted Average Diluted Share | $43.7M | $45.6M | $46.5M | $52M | $46.2M | |
| EBITDA | $71.4M | $161.4M | $162.4M | $162.9M | $176.4M | |
| EBIT | $51.5M | $132.8M | $70.9M | $87.3M | $97.6M | |
| Revenue (Reported) | $429.6M | $541.5M | $666.8M | $675M | $701M | |
| Operating Income (Reported) | $51.5M | $132.8M | $70.9M | $87.3M | $97.6M | |
| Operating Income (Adjusted) | $51.5M | $132.8M | $70.9M | $87.3M | $97.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $127.7M | $167.5M | $163.9M | $168.6M | $179.5M | |
| Revenue Growth (YoY) | 8.71% | 31.12% | -2.11% | 2.84% | 6.49% | |
| Cost of Revenues | $36.6M | $65M | $54.1M | $53.2M | $48.6M | |
| Gross Profit | $91.1M | $102.5M | $109.9M | $115.4M | $130.9M | |
| Gross Profit Margin | 71.33% | 61.19% | 67.01% | 68.45% | 72.93% | |
| R&D Expenses | $11.6M | $19.4M | $20.8M | $19.1M | $26M | |
| Selling, General & Admin | $40.7M | $52M | $58.9M | $65.2M | $81.7M | |
| Other Inc / (Exp) | -$283K | -$11.1M | -$3.8M | -$161.6M | -- | |
| Operating Expenses | $60.4M | $80.7M | $88.8M | $93.4M | $117.8M | |
| Operating Income | $30.7M | $21.8M | $21.1M | $22M | $13.2M | |
| Net Interest Expenses | $7.3M | $9.9M | $3.5M | $4.7M | $4.3M | |
| EBT. Incl. Unusual Items | $24.2M | $2.1M | $16.6M | -$138.9M | $9.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.6M | $2.8M | $5.7M | $4.6M | $4.1M | |
| Net Income to Company | $17.7M | -$693K | $10.9M | -$143.5M | $5.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $17.7M | -$693K | $10.9M | -$143.5M | $5.4M | |
| Basic EPS (Cont. Ops) | $0.40 | -$0.02 | $0.23 | -$3.11 | $0.12 | |
| Diluted EPS (Cont. Ops) | $0.39 | -$0.02 | $0.23 | -$3.11 | $0.12 | |
| Weighted Average Basic Share | $44.5M | $45.8M | $46.4M | $46.1M | $44M | |
| Weighted Average Diluted Share | $45.5M | $45.8M | $52.1M | $46.1M | $44.5M | |
| EBITDA | $36.5M | $42M | $39.5M | $42.2M | $34.3M | |
| EBIT | $30.7M | $21.8M | $21.1M | $22M | $13.2M | |
| Revenue (Reported) | $127.7M | $167.5M | $163.9M | $168.6M | $179.5M | |
| Operating Income (Reported) | $30.7M | $21.8M | $21.1M | $22M | $13.2M | |
| Operating Income (Adjusted) | $30.7M | $21.8M | $21.1M | $22M | $13.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $513.3M | $654.1M | $665.7M | $695M | $716.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $144.4M | $227M | $256.2M | $235.5M | $206.6M | |
| Gross Profit | $368.9M | $427.1M | $409.5M | $459.4M | $510.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $55.4M | $82.8M | $74.3M | $77.1M | $103.4M | |
| Selling, General & Admin | $169.6M | $208M | $233.1M | $245.9M | $305.8M | |
| Other Inc / (Exp) | -$11.3M | -$38.9M | -$40.5M | -$159.2M | -- | |
| Operating Expenses | $256.3M | $325.5M | $341.9M | $357.4M | $450.2M | |
| Operating Income | $112.6M | $101.6M | $67.6M | $102M | $60M | |
| Net Interest Expenses | $28.4M | $39.4M | $28M | $15.3M | $18.2M | |
| EBT. Incl. Unusual Items | $75.3M | $25.2M | $9.9M | -$54.9M | $41.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13.7M | $4.3M | $2.9M | $35.8M | $20.4M | |
| Net Income to Company | $61.6M | $20.9M | $7M | -$90.7M | $21.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $61.6M | $20.9M | $7M | -$90.7M | $21.4M | |
| Basic EPS (Cont. Ops) | $1.40 | $0.46 | $0.15 | -$1.97 | $0.47 | |
| Diluted EPS (Cont. Ops) | $1.36 | $0.40 | $0.08 | -$2.05 | $0.45 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $133.1M | $175.7M | $155.1M | $178M | $150.9M | |
| EBIT | $112.6M | $101.6M | $67.6M | $102M | $60M | |
| Revenue (Reported) | $513.3M | $654.1M | $665.7M | $695M | $716.8M | |
| Operating Income (Reported) | $112.6M | $101.6M | $67.6M | $102M | $60M | |
| Operating Income (Adjusted) | $112.6M | $101.6M | $67.6M | $102M | $60M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $382.3M | $494.9M | $493.7M | $513.7M | $529.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $107.1M | $180.3M | $179.9M | $173.5M | $152.4M | |
| Gross Profit | $275.2M | $314.5M | $313.8M | $340.2M | $377.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $40M | $67.3M | $56.8M | $57.7M | $79.5M | |
| Selling, General & Admin | $124.8M | $164.3M | $178.4M | $188.5M | $235M | |
| Other Inc / (Exp) | -$4.9M | $1.9M | -$16.5M | -$158.9M | -$13.2M | |
| Operating Expenses | $188.2M | $257.8M | $260.4M | $272.2M | $346.7M | |
| Operating Income | $87M | $56.7M | $53.4M | $68M | $30.5M | |
| Net Interest Expenses | $21.3M | $28.9M | $16.9M | $11.9M | $13.6M | |
| EBT. Incl. Unusual Items | $62.6M | $31.4M | $28M | -$88.6M | $16.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $15.5M | $5.4M | $10.9M | $27M | $10.9M | |
| Net Income to Company | $47.1M | $26M | $17.1M | -$115.6M | $5.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $47.1M | $26M | $17.1M | -$115.6M | $5.4M | |
| Basic EPS (Cont. Ops) | $1.07 | $0.57 | $0.37 | -$2.51 | $0.12 | |
| Diluted EPS (Cont. Ops) | $1.03 | $0.51 | $0.30 | -$2.53 | $0.12 | |
| Weighted Average Basic Share | $132.5M | $136.2M | $138.5M | $138.8M | $135.8M | |
| Weighted Average Diluted Share | $137M | $144.7M | $150.1M | $148.9M | $136.4M | |
| EBITDA | $102.5M | $117.8M | $110.4M | $125.6M | $100.1M | |
| EBIT | $87M | $56.7M | $53.4M | $68M | $30.5M | |
| Revenue (Reported) | $382.3M | $494.9M | $493.7M | $513.7M | $529.5M | |
| Operating Income (Reported) | $87M | $56.7M | $53.4M | $68M | $30.5M | |
| Operating Income (Adjusted) | $87M | $56.7M | $53.4M | $68M | $30.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $521.7M | $656.4M | $288.7M | $278.6M | $484.6M | |
| Short Term Investments | $421.7M | $70.8M | $184.5M | $125.3M | $207.8M | |
| Accounts Receivable, Net | $53M | $96.3M | $98.4M | $105.6M | $113.3M | |
| Inventory | $64.7M | $98.6M | $96.1M | $104.4M | $125.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $12.3M | $14.8M | $15.2M | $21.5M | $21.9M | |
| Total Current Assets | $651.6M | $866M | $498.3M | $510M | $745.1M | |
| Property Plant And Equipment | $211.2M | $264.8M | $254.4M | $234.9M | $216.4M | |
| Long-Term Investments | $95.5M | -- | $37.2M | $2.4M | -- | |
| Goodwill | $99.5M | $145.2M | $163.2M | $163.2M | -- | |
| Other Intangibles | $96.5M | $624M | $540.5M | $483.3M | $426M | |
| Other Long-Term Assets | $14M | $22M | $27.2M | $36M | $35.6M | |
| Total Assets | $1.3B | $2.1B | $1.7B | $1.6B | $1.6B | |
| Accounts Payable | $10.4M | $10.5M | $15.2M | $15.7M | $19.1M | |
| Accrued Expenses | $48.8M | $82.1M | $63.6M | $42.6M | $51.3M | |
| Current Portion Of Long-Term Debt | $149.6M | $374.7M | $33.6M | $8.6M | $201.8M | |
| Current Portion Of Capital Lease Obligations | $7.4M | $7.9M | $9.1M | $8.8M | $8.9M | |
| Other Current Liabilities | $14.7M | -- | -- | -- | -- | |
| Total Current Liabilities | $253.3M | $521.1M | $147.8M | $97.4M | $309.9M | |
| Long-Term Debt | $384.1M | $746.3M | $720.6M | $568.6M | $428.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $654.8M | $1.3B | $906.2M | $704.3M | $775.2M | |
| Common Stock | $44K | $45K | $46K | $46K | $47K | |
| Other Common Equity Adj | -- | $167K | -$380K | $247K | $343K | |
| Common Equity | $619.7M | $730.4M | $775M | $870.1M | $778.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $619.7M | $730.4M | $775M | $870.1M | $778.3M | |
| Total Liabilities and Equity | $1.3B | $2.1B | $1.7B | $1.6B | $1.6B | |
| Cash and Short Terms | $521.7M | $656.4M | $288.7M | $278.6M | $484.6M | |
| Total Debt | $533.7M | $1.1B | $754.3M | $577.2M | $630M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $693.9M | $328.7M | $235.2M | $453.8M | $246.3M | |
| Short Term Investments | $559.8M | $219.3M | $136.1M | $207.8M | -- | |
| Accounts Receivable, Net | $50M | $93.5M | $97M | $100.7M | $115.3M | |
| Inventory | $67.2M | $96.8M | $96.5M | $111.9M | $157.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $11.3M | $14.4M | $18.6M | $23.6M | -- | |
| Total Current Assets | $822.4M | $533.4M | $447.3M | $690M | $562.8M | |
| Property Plant And Equipment | $229M | $263.3M | $239.2M | $220.7M | $191.7M | |
| Long-Term Investments | -- | $17.4M | -- | -- | -- | |
| Goodwill | $99.5M | $157.4M | $163.2M | -- | -- | |
| Other Intangibles | $90.6M | $581M | $497.6M | $440.3M | -- | |
| Other Long-Term Assets | $21.2M | $26.4M | $35.5M | -- | -- | |
| Total Assets | $1.4B | $1.7B | $1.5B | $1.5B | $1.3B | |
| Accounts Payable | $7.9M | $12.9M | $16.5M | $19.4M | $17.7M | |
| Accrued Expenses | $50.8M | $76.4M | $59.9M | $76.4M | -- | |
| Current Portion Of Long-Term Debt | $155.8M | $33.9M | $8.6M | $201.5M | -- | |
| Current Portion Of Capital Lease Obligations | $5.9M | $8.4M | $8.6M | $9.2M | -- | |
| Other Current Liabilities | $5.1M | -- | -- | -- | -- | |
| Total Current Liabilities | $225.8M | $131.5M | $93.7M | $306.4M | $107.1M | |
| Long-Term Debt | $392.9M | $779.4M | $573M | $433.8M | $415.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $637.4M | $964.2M | $702.9M | $772.1M | $570.4M | |
| Common Stock | $45K | $46K | $46K | $47K | $48K | |
| Other Common Equity Adj | -- | -- | -$10K | $678K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $718.6M | $770.1M | $831.6M | $749.6M | $727.2M | |
| Total Liabilities and Equity | $1.4B | $1.7B | $1.5B | $1.5B | $1.3B | |
| Cash and Short Terms | $693.9M | $328.7M | $235.2M | $453.8M | $246.3M | |
| Total Debt | $548.7M | $813.3M | $581.7M | $635.2M | $415.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $145.5M | $42M | $15.9M | $42M | -$99.6M | |
| Depreciation & Amoritzation | $19.9M | $28.5M | $91.5M | $75.6M | $78.8M | |
| Stock-Based Compensation | $39.9M | $42.2M | $48.1M | $47.9M | $51.2M | |
| Change in Accounts Receivable | -$5.5M | -$10.4M | -$2.1M | -$7.2M | -$7.7M | |
| Change in Inventories | -$6.4M | -$4.5M | $2.5M | -$8.3M | -$20.9M | |
| Cash From Operations | $77M | $125.7M | $145.3M | $154.6M | $189.4M | |
| Capital Expenditures | $37.8M | $45.9M | $30.1M | $15.2M | $10.6M | |
| Cash Acquisitions | -- | $420M | -- | -- | -- | |
| Cash From Investing | -$277.6M | -$20.8M | -$225.2M | $77.5M | -$83.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $402.5M | $363.8M | -- | $149.6M | $287.5M | |
| Long-Term Debt Repaid | -$209.9M | -- | -$427.7M | -$330.3M | -$210.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | $25M | |
| Other Financing Activities | -$18.1M | -$9.7M | -$1.2M | -$7M | -$36.6M | |
| Cash From Financing | $222.3M | $380.7M | -$401.5M | -$183M | $17.4M | |
| Beginning Cash (CF) | $100M | $585.6M | $104.1M | $153.3M | $276.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $21.7M | $485.6M | -$481.4M | $49.2M | $123.5M | |
| Ending Cash (CF) | $121.7M | $1.1B | -$377.3M | $202.5M | $400.3M | |
| Levered Free Cash Flow | $39.2M | $79.9M | $115.2M | $139.5M | $178.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $17.7M | -$693K | $10.9M | -$143.5M | $5.4M | |
| Depreciation & Amoritzation | $5.7M | $20.2M | $18.4M | $20.3M | $21.2M | |
| Stock-Based Compensation | $10.8M | $12.7M | $12.5M | $13.2M | $14M | |
| Change in Accounts Receivable | $18.4M | -$2.4M | $2.1M | $4.1M | -$897K | |
| Change in Inventories | -$1.9M | $3.8M | -$4.4M | -$8.4M | -$9.5M | |
| Cash From Operations | $60.3M | $42.7M | $44.4M | $53.9M | $60.8M | |
| Capital Expenditures | $13.1M | $5.2M | $3.4M | $4.1M | $3.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$35.1M | -$47.5M | -$4.3M | -$52.2M | $43.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$9.4M | -$27.8M | -$2.8M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $50M | |
| Other Financing Activities | -- | -- | -- | $26.7M | -- | |
| Cash From Financing | $3.1M | -$7.8M | -$27.8M | -$2.8M | -$257.5M | |
| Beginning Cash (CF) | $134M | $109.4M | $99.1M | $246M | $147.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $28.3M | -$12.6M | $12.3M | -$1.1M | -$152.9M | |
| Ending Cash (CF) | $162.3M | $96.8M | $111.4M | $244.9M | -$5.3M | |
| Levered Free Cash Flow | $47.2M | $37.5M | $41M | $49.8M | $57M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $61.6M | $20.9M | $7M | -$90.7M | $21.4M | |
| Depreciation & Amoritzation | $20.5M | $74.2M | $87.5M | $76M | $90.9M | |
| Stock-Based Compensation | $42.3M | $46.3M | $48.2M | $51.3M | $56.3M | |
| Change in Accounts Receivable | -$3.8M | -$10.7M | -$3.5M | -$3.7M | -$14.6M | |
| Change in Inventories | $1.3M | -$156K | $278K | -$15.3M | -$45.8M | |
| Cash From Operations | $149.2M | $126.5M | $149.1M | $203.8M | $141.4M | |
| Capital Expenditures | $51.1M | $33.8M | $18.9M | $10.3M | $17.2M | |
| Cash Acquisitions | -- | $420M | -- | -- | $16.7M | |
| Cash From Investing | -$170M | -$169.5M | $80.4M | -$74.5M | $79.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $149.6M | $287.5M | -- | |
| Long-Term Debt Repaid | -- | -$368.3M | -$386.9M | -$210.9M | -- | |
| Repurchase of Common Stock | -- | -- | -- | $25M | $100.1M | |
| Other Financing Activities | -- | -- | -- | -$9.9M | -- | |
| Cash From Financing | $29.6M | $18.4M | -$239.8M | $17.5M | -$319.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.8M | -$24.6M | -$10.3M | $146.8M | -$98.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $98.1M | $92.7M | $130.2M | $193.5M | $124.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $47.1M | $26M | $17.1M | -$115.6M | $5.4M | |
| Depreciation & Amoritzation | $15.5M | $61.1M | $57.1M | $57.5M | $69.7M | |
| Stock-Based Compensation | $31.4M | $35.4M | $35.5M | $38.9M | $44M | |
| Change in Accounts Receivable | $3.1M | $2.8M | $1.4M | $4.9M | -$1.9M | |
| Change in Inventories | -$2.6M | $1.8M | -$457K | -$7.5M | -$32.4M | |
| Cash From Operations | $102.5M | $103.2M | $107.1M | $156.3M | $108.3M | |
| Capital Expenditures | $36.7M | $24.6M | $13.4M | $8.5M | $15.1M | |
| Cash Acquisitions | -- | -- | -- | -- | $16.7M | |
| Cash From Investing | -$87.7M | -$236.4M | $69.2M | -$82.9M | $80.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $149.6M | $287.5M | -- | |
| Long-Term Debt Repaid | -- | -$368.3M | -$327.5M | -$208.1M | -$6.6M | |
| Repurchase of Common Stock | -- | -- | -- | $25M | $100.1M | |
| Other Financing Activities | -$1.3M | -- | -$6.9M | -$9.8M | -$5.5M | |
| Cash From Financing | $19.3M | -$343M | -$181.3M | $19.3M | -$318M | |
| Beginning Cash (CF) | $306.5M | $458.2M | $221.5M | $677.1M | $731.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $34.1M | -$476.2M | -$5M | $92.7M | -$129.2M | |
| Ending Cash (CF) | $340.6M | -$17.9M | $216.5M | $769.7M | $602.5M | |
| Levered Free Cash Flow | $65.8M | $78.7M | $93.7M | $147.7M | $93.2M | |
Get PCRX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PCRX
Sector
P/E ratio
58.33x
23.89x
PEG ratio
--
-0.01x
P/B ratio
1.54x
1.82x
Price / LTM sales
1.68x
1.60x
Growth Metrics
PCRX
Sector
Revenue growth
6.49%
4.62%
Earnings growth
103.93%
10.88%
Revenue (5-year growth)
10.73%
6.5%
Earnings forecast
$0.65
-$0.21
Profitability
PCRX
Sector
Profitability FY 2024
$473.3M
$3.5M
Return on invested capital
1.58%
-31.77%
Return on assets
1.43%
-27.96%
Return on equity
2.81%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
PCRX
Sector
Total cash
$246.3M
$26.3M
Short term investments
$207.8M
$25.7M
Total assets
$1.6B
$78M
Long term debt
$415.6M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
